In postural tachycardia syndrome (POTS) patients, changes in NET expression were attributed to increased binding of the repressive MeCP2 regulatory complex, in association with an altered histone modification composition at the promoter region of the SCL6A2 gene (Bayles et al., 2012). Here, MECP2 is linked to postural orthostatic tachycardia syndrome.